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Abstract
Background: Human multipotent mesenchymal stromal cells (MSC) can be isolated from various tissues including
bone marrow. Here, MSC participate as bone lining cells in the formation of the hematopoietic stem cell niche. In
this compartment, the oxygen tension is low and oxygen partial pressure is estimated to range from 1% to 7%. We
analyzed the effect of low oxygen tensions on human MSC cultured with platelet-lysate supplemented media and
assessed proliferation, morphology, chromosomal stability, immunophenotype and plasticity.
Results: After transferring MSC from atmospheric oxygen levels of 21% to 1%, HIF-1a expression was induced,
indicating efficient oxygen reduction. Simultaneously, MSC exhibited a significantly different morphology with
shorter extensions and broader cell bodies. MSC did not proliferate as rapidly as under 21% oxygen and
accumulated in G1 phase. The immunophenotype, however, was unaffected. Hypoxic stress as well as free oxygen
radicals may affect chromosomal stability. However, no chromosomal abnormalities in human MSC under either
culture condition were detected using high-resolution matrix-based comparative genomic hybridization. Reduced
oxygen tension severely impaired adipogenic and osteogenic differentiation of human MSC. Elevation of oxygen
from 1% to 3% restored osteogenic differentiation.
Conclusion: Physiologic oxygen tension during in vitro culture of human MSC slows down cell cycle progression
and differentiation. Under physiological conditions this may keep a proportion of MSC in a resting state. Further
studies are needed to analyze these aspects of MSC in tissue regeneration.
Background
Human multipotent mesenchymal stromal cells (MSC)
obtained from bone marrow are characterized by a mul-
tilineage differentiation potential and a high proliferative
capacity without losing their genetic stability [1]. By the
mid of the last decade, the clinical potential was recog-
nized [2]. Today, several clinical trials showed that the
application of ex vivo expanded MSC is safe and feasible
[3-5]. MSC have earned considerable attention as thera-
peutic tools in graft-versus-host disease after allogeneic
hematopoietic stem cell transplantation [6]. The treat-
ment of pediatric patients suffering from osteogenesis
imperfecta was the first successful clinical application of
MSC in regenerative medicine [3,7]. Another promising
application of MSC has been explored in a pilot study
where five children with steroid-induced osteonecrosis
of the femur received MSC directly injected into the
necrotic area of the bone [8]. Regenerative properties of
MSC could also be demonstrated in the treatment of
ischemic cardiovascular diseases [9].
These examples of tissue regeneration share the phe-
nomenon of oxygen deprivation in the affected organs
challenging the ability of MSC to differentiate into bone
or other tissues [10]. Physiologically the cells are
adapted to low oxygen levels with oxygen concentra-
tions between 1% and 7%. Mathematical models of the
pO2 distribution in human bone marrow suggest a gra-
dient across the marrow from the relatively well oxyge-
nated sinuses to the rather hypoxic endosteal region
[11]. It is known that low oxygen tension is involved in
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plasticity [12]. Conversely, hypoxia may also serve as a
danger signal and recruit MSC. In a rat model, Roche-
fort and colleagues showed that specifically MSC and
not hematopoietic progenitor cells were mobilized out
of the bone marrow into the peripheral blood by
hypoxia [13]. However, it is an open issue if various oxy-
gen concentrations over prolonged periods of time
change the characteristic properties which define MSC
in vitro as proposed by the International Society for Cel-
lular Therapy [14]. Reports addressing this issue
obtained conflicting results: In several in vitro studies,
low oxygen concentrations have been found to be sti-
mulating differentiation processes, exemplarily shown by
inducing the cells toward the adipogenic, osteogenic or
chondrogenic lineage [15-17]. In contrast, other groups
reported suppressive effects of reduced oxygen tensions
on MSC plasticity [10,18]. It is hypothesized that survi-
val and proliferative capacity of MSC can be enhanced
by maintaining the cells under low oxygen tensions.
Standard culture of MSC at 21% O2 imply hyperoxic
conditions compared to physiological O2 concentrations,
i. e. 1% - 7%, with increased oxidative stress and subse-
quent chromosomal instability and thereby possibly con-
tribute to the limited growth rates [19]. In addition,
subtle differences of culture conditions such as growth
factor supplementation of the media may contribute to
the heterogeneity of the results.
MSC contribute to the niche for hematopoietic stem
cells (HSC) in the bone marrow which consists of three
compartments: the bony niches lined with osteoblasts
proximal to the endosteal surface, the stromal niche
contained within the sinusoidal endothelial cells in the
medulla of the bone, and adipocytes [20]. It was shown
in animal models that regional blood supply and level of
oxygenation directly affect localization and stemness of
HSC. The most primitive hematopoietic progenitor cells
are sequestered in niches at the lowest end of an oxygen
g r a d i e n tw h e r et h e ya r em a i n tained in an undifferen-
tiated state and mainly act via trophic factor secretion.
Towards higher oxygen levels, expansion and differentia-
tion of HSC increases [21,22].
We hypothesized that MSC and HSC share similar
responses to varying oxygen concentrations concerning
alterations in their phenotypic and functional properties.
Therefore, we assessed morphology, proliferation
kinetics, cell cycle characteristics, immunophenotype,
plasticity and chromosomal stability of MSC maintained
at atmospheric and physiological, i. e. low oxygen ten-
sions. Regarding the discrepancies between previous stu-
dies in the field, it is important to note that platelet
lysate was used as growth supplement, because it is
gaining attention for clinical application of MSC. More-
over, prolonged incubation periods and minimal oxygen
concentrations of 1% were used to mimic the microen-
vironment, which may also occur in therapeutic situa-
tions of regenerative medicine.
Results
Effect of physiological oxygen concentrations on MSC
morphology
The cell morphology under reduced oxygen tension and
under atmospheric conditions was analyzed via light
microscopy with photomicrographs taken at the time
p o i n t so f1w e e ka n d3w e e k s .W eo b s e r v e dt w od i f f e r -
ent behaviors and sensitivities to oxygen deprivation.
Figure 1 shows photomicrographs of two representative
donors: MSC of donor 1 cultured in either 21% O2 or
1% O2 over 3 weeks were morphologically indistinguish-
able. Both populations could be seen as colonies of tri-
angular cells after several days of culture. As the cells
adhered to plastic, the nonadherent hematopoietic cells
in the culture were removed during changes of medium
and virtually homogenous cultures with the characteris-
tic confluent, spindle-shaped MSC were obtained after
three passages. The population grown under atmo-
spheric conditions of donor 2 showed the characteristic
time course of MSC morphology as described for donor
1. In contrast, the population of donor 2 maintained in
1% O2 neither adapted the typical triangular shape nor
did it become a confluent, plastic-adherent monolayer,
but died after one week (D). Thus, MSC morphology
under reduced oxygen tension is also donor dependent.
These experiments were repeated with a total of ten dif-
ferent pediatric donors as summarized in table 1.
Effect of reduced oxygen concentrations on MSC
immunophenotype
The immunophenotype of human MSC is characterized
by the cell surface expression of CD73, CD90, CD105,
CD106, CD146 and MHC class I. Furthermore, the
absence of hematopoietic markers such as CD45 and of
CD34 or MHC class II is used to identify culture
expanded MSC. We analyzed these markers by flow
Table 1 Characteristics of MSC donors and MSC cultures.
Age in years Sex Status of MSC in 21% and 1% O2
1 M Disintegration of MSC after 7 days under 1% O2
1 W No differences after 3 weeks
4 M No differences after 3 weeks
5 W No MSC after 7 days under 1% O2
5 M Disintegration of MSC after 7 days under 1% O2
6 M No MSC after 7 days under 1% O2
11 M No differences after 3 weeks
13 M Disintegration of MSC after 7 days under 1% O2
14 M No MSC after 7 days under 1% O2
18 M Disintegration of MSC after 7 days under 1% O2
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Page 2 of 11cytometry in cells from three different donors cultured
at 21% O2 and at 1% O2. Only cultures of donors whose
c e l l ss u r v i v e da t1 %O 2 were used in this set of experi-
ments. There was no significant difference in cell surface
expression of the markers mentioned above after 14
days of culture at the indicated oxygen tension (figure
2).
Effect of physiological oxygen concentrations on the
expression of hypoxia-inducible factor-1a
HIF-1a is induced at low oxygen concentrations. We
investigated the mRNA levels of the transcription factor
in MSC, which had been expanded at 21% O2 and 1%
O2 in order to prove efficiency of oxygen reduction in
our experimental setting. Under atmospheric culture
conditions HIF-1a expression was detected at a low
level as assessed by reverse transcription PCR. In
contrast, the relative index for HIF-1a expression, which
was obtained by normalizing HIF-1a against GAPDH
intensity, increased more than 3-fold when the cells had
been grown at low oxygen tensions. Hence, near physio-
logical oxygen concentrations upregulated the expres-
sion of hypoxia-inducible factor-1a at the mRNA level
(figure 3A).
Effect of physiological oxygen concentrations on
proliferation of MSC
The use of subatmospheric oxygen concentrations dur-
ing in vitro culture of human MSC was found to be sti-
mulating in some publications and inhibitory in others.
To assess the effect of platelet-derived growth factors in
our GMP-conform culture conditions, we analyzed pro-
liferation of MSC under atmospheres of 21%, 5%, 3%
and 1% O2 by an MTS proliferation assay. In our
Figure 1 Morphological evaluation of MSC under different oxygen conditions. Photomicrographs of two representative MSC cultures from
separate donors. In one culture no significant morphological difference after 3 weeks between 21% O2 (A) and 1% O2 (B) were found. In a
second culture, MSC under 1% O2 did not adapt the typical triangular shape and became plastic-adherent, but died after 1 week (D), while the
control cells maintained under 21% O2 (C) exhibited the characteristic MSC morphology. Obviously, donor-dependent factor greatly impact the
growth and differentiation behavior of MSC under these conditions. Out of 10 cultures 3 showed growth under both oxygen tensions, whereas
7 displayed less tolerance to low oxygen tension of 1%.
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tion after an incubation period of seven days (figure 3B-
D). At an oxygen concentration of 21%, which is hyper-
oxic in comparison to the physiological environment of
MSC, cell proliferation was vigorous. The proliferation
rate and metabolic activity declined depending on the
oxygen concentration tested.
To further corroborate these results, we analyzed cell
cycle progression of MSC under 21% and 1% oxygen
atmospheres. Figure 4 shows the cell cycle analysis of
human MSC after a period of 7 days at the chosen cul-
ture conditions. Only 1.37% of MSC had entered the
G2/M phase in the hypoxic cell culture in comparison
to 2.50% at an oxygen concentration of 21%. Similar
results were obtained after an adaptation period of 3
weeks (data not shown). This decrease of cells in the
G2/M phase confirms the inhibitory effect of reduced
oxygen concentrations on MSC proliferation in our
experimental setting.
Chromosomal stability of MSC at different oxygen
tensions
Environmental stress by low and high oxygen concentra-
tions, respectively, may affect chromosomal stability of
MSC and thereby contribute to the different biological
properties observed so far. Moreover, chromosomal
stability of MSC under these conditions is relevant for
preparation of MSC and clinical application in tissue
regeneration. We performed high-resolution matrix-
based comparative genomic hybridization of three inde-
pendent MSC samples after 4 weeks of cell culture. No
chromosomal aberrations were detected (figure 5).
Effect of low oxygen concentrations on MSC plasticity
Besides growth factor secretion, the potential of MSC as
therapeutic tools in regenerative medicine is determined
by their ability to differentiate into various tissues.
Therefore, MSC grown under reduced oxygen and
atmospheric conditions were analyzed for their capabil-
ity to differentiate into adipocytes and osteoblasts as
proof of plasticity. Culture of MSC in adipogenic induc-
tion medium for 14 days under 21% O2 resulted in the
appearance of adipocyte-like cells containing lipid dro-
plets, which stained positive with Oil-Red-O (figure 6B).
The same phenomenon could be observed with cells
cultured at 1% O2, but to a lesser extent (figure 6D).
The osteogenic differentiation potential under both con-
ditions was evaluated by Alizarin Red-S staining of cal-
cium precipitates after 14 days of culture in osteogenic
induction medium. Figure 6F shows that MSC differen-
tiated into osteoblasts at 21% O2 as the deposition of
calcium precipitates could be detected, but not at 1% O2
Figure 2 Immunophenotyping profile of MSC under 21% O2 (A) and 1% O2 (B) by flow cytometric analysis of cell surface marker
expression after 14 days showed no changes in immunophenotype of MSC due to varying oxygen concentrations (n = 3).
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towards small changes in oxygen tension, we performed
the osteogenic differentiation at 3% O2 as well. Interest-
ingly, these assays showed no detectable difference in
comparison to 21% O2 (figure 6J).
Discussion
Oxygen concentration during standard in vitro culture
of primary human cells is often not adapted to the in
vivo situation. The bone marrow is a compartment with
an oxygen concentration of 1% to 7%, increasing from
the endosteal lining cells to the sinusoid lining cells
[11]. It is becoming evident that oxygen is a regulator of
stem cell biology [23]. As MSC in bone marrow are
usually found as bone lining cells, they are exposed to
considerably lower oxygen concentrations in vivo than
in vitro. This artificial situation has prompted several
groups to investigate key features of MSC with
conflicting results [10,12,15,16,18,19]. The inconsistency
of these results was possibly due to a number of varia-
tions in the experimental setup, including (i) use of
MSC from different species, namely rodents and
humans; (ii) different media composition, in particular
source and amount of growth factors; and (iii) subtle
differences in the oxygen concentrations used from 8%
to 1%. This prompted us to investigate human MSC,
which are kept in media supplemented with platelet
lysate and human plasma [24-28]. This media is increas-
ingly used for expansion of human MSC prior to clinical
applications under GMP-conform conditions [8,29].
We found that human MSC in platelet-lysate supple-
mented media show a reduced growth rate under oxy-
gen supply close to what is expected in vivo.T h i s
finding is in agreement with data obtained for hemato-
poietic stem cells [21] as for MSC [10]. In the stem cell
niche, which is located close to the endosteum, low
Figure 3 HIF-1a upregulation in response to low oxygen tension. Exposure of MSC to hypoxia resulted in a more than 3-fold increase of
the HIF-1a expression as detected by semiquantitative RT-PCR. The relative index for HIF-1a was normalized against GAPDH relative intensity.
Effect of reduced oxygen tension on MSC proliferation kinetics (A). Cell proliferation was measured by an increase in OD using the MTS assay
after an incubation period of 7 days under 21% O2,5 %O 2 (B), 3% O2 (C), and 1% O2 (D), respectively. Values indicate the mean and standard
deviation for 3 cultures of each condition. Significance for all analysis was set at *** p < 0,001, ** p < 0,01, * p < 0,05 using student’s t-test.
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state and maintains plasticity. Here, the role of HIF1a,
which is upregulated under hypoxic conditions, plays an
important role in concert with bFGF [30]. Furthermore,
HIF1a sensitizes cells to bFGF and vice versa [31,32].
These oberservations are candidate mechanisms for
maintaining MSC in a more quiescent, more plastic
state, because bFGF was shown to maintain plasticity in
a closely related fibroblastic population isolated from
the nucleus pulposus [33]. Differences in bFGF-content
in FCS and human plasma/platelet lysate may contribute
to some of the different results obtained in previous
reports.
MSC in a slowly cycling state may be more protected
from DNA damage caused by errors during replication
as well as from free oxygen radical species. In this
respect it is not surprising that MSC do not proliferate
and differentiate under reduced oxygen levels as com-
pared to atmospheric oxygen levels. Although we have
not detected chromosomal aberration during the culture
period in our CGH assay, mutations could be favored by
high oxygen tensions during conventional culture condi-
tions. We therefore limit the culture period in our insti-
tution for clinical application of human MSC to four
weeks as a safety measure.
These results may contribute to a better understand-
ing of the regenerative potential displayed by MSC in
ischemic tissue. Several groups including our own have
shown, that MSC do not only contribute to tissue
repair by transdifferentiation, but also by secretion of
trophic factors or angiogenic cytokines [8,34,35]. It
may depend to a large extent on other cytokines in the
damaged tissue and even on the donor, how MSC sti-
mulate tissue regeneration in a given setting. The
microenvironment will play an important role in the
biological function of MSC. Even minimal changes
have significant impact on biological properties of
MSC as can be seen from the fact that increasing the
oxygen from 1% to 3% during osteogenic induction
almost completely restored this plasticity (figure 6).
The situation of regenerating necrotic tissue cannot be
compared with the stem cell niche in bone marrow.
Inflammatory cytokines are present in the areas of
ischemic tissue in high concentrations [36]. Therefore,
the biological behavior of MSC is most likely different
in both situations, as MSC are sensitive to proinflam-
matory cytokines and change their gene expression
profile rapidly [37,38].
Conclusions
Our data demonstrate that human MSC show reduced
proliferation rates and accumulation in G1 phase when
cultured in platelet lysate supplemented media under
strongly reduced oxygen concentrations. Moreover,
MSC exhibit a pronounced reduction in differentiation
into adipose and bone tissue under these conditions as
compared with atmospheric oxygen. Future experiments
directed at gene expression profiling under these condi-
tions in the presence or absence of proinflammatory
cytokines may help to understand the mechanisms
underlying the quiescent state and the regenerative
activity of human MSC.
Figure 4 Flow cytometric cell cycle analysis of MSC under atmospheric and reduced oxygen conditions. Cells were permeabilized and
stained with propidium iodide. DNA content-related cell cycle distribution of MSC after 7 days of incubation under 21% O2 and 1% O2 (n = 3).
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Isolation and culture of MSC
MSC were obtained from excessive material of diagnos-
tic bone marrow aspirates of children with hematopoie-
tic malignancies after informed consent and approval by
the local IRB (241/2005V). MSC cultures were estab-
lished as described earlier [25]. Briefly, bone marrow
samples (0.5 ml) were heparinized, subjected to red
blood cell lysis using the ammonium chloride method,
and washed with Hank’sb u f f e r e ds a l ts o l u t i o n( L o n z a ,
Basel, Switzerland). Cells were placed in low glucose
Dulbecco’s Modified Eagle Medium (LG-DMEM, Lonza)
supplemented with 5% (v/v) human fresh frozen plasma
(FFP), 10
7/ml platelets (University of Tübingen blood
donor centre), 80 IU/ml heparin sulphate, 1 mM gluta-
mine (Lonza), 100 IU/ml penicillin, 100 μg/ml strepto-
mycin (both Biochrom, Berlin, Germany) in one well of
a six-well culture plate. Nonadherent cells were purged
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Figure 5 Effect of hypoxia on chromosomal stability. Chromosomal aberrations were not detectable by high-resolution matrix-based
comparative genomic hybridization after 4 weeks of MSC culture at 21% O2 and 1% O2. Except for typical polymorphisms, the DNA of MSC did
not show any chromosomal abnormalities compared to freshly isolated DNA from PBMC of healthy volunteers (n = 3).
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Page 7 of 11Figure 6 Effect of hypoxia on MSC plasticity. Oil-Red-O stain of MSC in adipogenic induction medium at atmospheric and reduced oxygen
concentrations after 14 days of culture: (A) 21% O2. control; (B) 21% O2. adipogenic induction; (C) 1% O2. control; (D) 1% O2. adipogenic
induction. Alizarin Red-S staining for the deposition of calcium precipitates is an indicator for the osteogenic differentiation. Viability and
osteogenic differentiation of MSC from most donors was drastically reduced in this medium under 1% O2 as compared to 21% O2: (E) 21% O2.
control; (F) 21% O2. osteogenic induction; (G) 1% O2. control; (H) 1% O2. osteogenic induction. However, a slight increase of oxygen to 3%
allowed for efficient differentiation of MSC into osteoblasts: (I) 3% O2. control; (J) 3% O2. osteogenic induction. Three independent experiments
of adipogenic and osteogenic differentiation were performed.
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Page 8 of 11on day 2 and medium was replaced twice a week. At
80% confluence, cells were harvested with trypsin 0.5%
( L o n z a )a n dr e p l a t e di nt h ea b o v em e d i u ma t2 , 0 0 0
cells/cm
2. To expand the cells, successive passages were
performed with the same protocol for a maximum of six
weeks.
Equal numbers of culture dishes of the same donor
were kept in Heracell gas addition incubators (Heraeus
Instruments GmbH, Hanau, Germany) with gas mix-
tures consisting of either 21% O2,7 4 %N 2,5 %C O 2
(referred to as 21% O2), 1% O2,9 4 %N 2,5 %C O 2
(referred to as 1% O2)o r3 %O 2, 92% N2,5 %C O 2
(referred to as 3% O2)f o ra tl e a s to n ew e e kb e f o r ep e r -
forming an experiment.
Proliferation
After 7 days of adaptation in 21%, 3% and 1% O2,
respectively, MSC were plated in a 96 well plate at a
density of 6,250 cells/cm
2 a n dc u l t u r e df o ra n o t h e r7
days. Proliferation was analyzed using the MTS assay kit
according to the instructions of manufacturer (Promega,
Madison, WI).
Cell Cycle Analysis
Cell cycle analysis of MSC was performed after 7 days
and 21 days of adaptation in 21% O2 and 1% O2.1 0
6
MSC were washed with phosphate buffered saline (PBS,
Biochrom, Berlin, Germany) three times, fixed with ice-
cold 70% ethanol and stored at 4°C for a minimum of 1
hour. After three more washing steps with PBS, DNA
and RNA of the MSC were stained with propidium
iodide/RNase staining buffer (BD Biosciences, Heidel-
berg, Germany). The samples were incubated at room
temperature for 15 minutes and analyzed by flow cyto-
metry on a FACS Calibur (Becton Dickinson, Heidel-
berg, Germany).
Differentiation assays
The differentiation of MSC was assessed after an adap-
tation period of 14 days in 21% O2 and 1% O2 as
reported earlier [25].
Adipogenic differentiation was induced in 80% con-
fluent MSC cultures by supplementing the cell culture
medium with 1 μM dexamethasone, 60 μM indometha-
cin, 0.5 mM isobuthylmethylxanthine (all Sigma-Aldrich,
Steinheim, Germany) and 10 μMi n s u l i n( N o v o ,N o v o -
disk, Bagsværd, Denmark). After 14 to 20 days, histo-
chemical staining with Oil-Red-O (Sigma) was
performed to detect lipid droplet formation.
Osteogenic differentiation was induced in 50% con-
fluent MSC cultured in cell culture medium supplemen-
ted with 10 nM dexamethasone and 0.1 mM L-ascorbic
acid-2-phosphate (both Sigma) from day 0 to day 7. For
7 to 14 more days, 10 mM beta-glycerol phosphate
(Sigma) and 100 ng/ml bone morphogenic protein-2
(Tebu-Bio, Magenta, Italy) were added as additional cell
culture supplements. To verify the osteogenic
differentiation, calcium precipitates were detected by
aqueous 0.5% (v/v) Alizarin Red-S (Sigma) histochemical
staining. This differentiation was also performed at 3%
O2.
Immunophenotyping
MSC of the same donor were placed in 21% O2,3 %O 2
or in 1% O2 atmospheres for 14 days. Subsequently,
MSC were harvested, washed with PBS supplemented
with 2% Fetal Calf Serum (FCS, Biochrom) and stained
with the following antibodies: anti-IgG1-FITC (clone-
MOPC-31C), anti-IgG1-PE (clone G18-145), anti-CD45-
FITC (clone HI30), anti-CD34-PE (clone 563), anti-
CD73-PE (clone A02), anti-HLA-DR-FITC (clone
TÜ36), anti-HLA-ABC-PE (clone G46-2.6), all from
Becton Dickinson and anti-CD105-FITC (clone N1-3A1,
Ancell, Bayport, MN, USA), anti-CD90-PE (clone F15-
42-1), anti-CD106-FITC (clone 1.G11B1, both Serotec,
Düsseldorf, Germany) and anti-CD146-PE (clone P1H12
from Santa Cruz Biotechnology, Heidelberg, Germany).
The immunophenotype was analyzed using a FACS
Calibur and CellQuest analysis software (Becton
Dickinson).
Array-based Comparative Genomic Hybridization (array-
CGH, matrix-CGH)
Array- (or Matrix-) CGH [39] was carried out as pre-
viously described [40-42]. Selection of genomic clones,
isolation of BAC DNA, performance of DOP-PCR, pre-
paration of microarrays, labeling, hybridization and
washing procedures were performed as outlined. Raw
data processing and normalization was performed as
previously reported providing log2-ratios of spot intensi-
ties [43]. The chromosomal mapping information is
based on the University of California at Santa Cruz
(UCSC) genome database (March 2006) and the March
2006 (hg18) assembly (NCBI Build 36.1) of the Interna-
tional Human Genome Sequencing Consortium. All
clones from totally 11 samples were subjected to pre-
processing, which included elimination of clones with
incomplete mapping information or missing data in
more than 20% of cases. This resulted in 7980 clones
evaluable for further analysis. In the next step, genomic
events were assigned. The median of all MADs (median
absolute deviation) across all chromosomes is taken to
estimate the sample experimental variability (genomic
“standard deviation”,S D g). Gains and losses are defined
by log2-ratios larger than 3 times SDg or smaller than -
3 times SDg, respectively.
Semiquantitative Reverse Transcriptase-Polymerase Chain
Reaction
After 4 weeks of expansion in 21% and 1% O2,M S C
were harvested and total RNA was extracted using peq-
GOLD TriFast™ reagent (PEQLAB Biotechnologie
GmbH, Erlangen) according to the manufacturer’s
instructions. Complementary DNA (cDNA) was
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Page 9 of 11synthesized from 1 μg total RNA (Invitrogen, Gronin-
gen, The Netherlands) and amplification was done using
the following primers: HIF-1a, for: CTCAAAGTCGGA-
CAGCCTCA/rev: CCCTGCAGTAGGTTTCTGCT;
GAPDH, for: CGGGAAGCTTGTGATCAATGG/rev:
GGCAGTGATGGCATGGACTG. PCR conditions were:
HIF-1a, 94°C for 3 min/95°C for 30 s, 56°C for 30 s, 72°
C for 1 min (20 cycles)/72°C for 10 min; GAPDH, 95°C
for 2 min/95°C for 30 s, 55°C for 30 s, 72°C for 30 s (20
cycles)/72°C for 7 min. Products (358 bp) were sepa-
rated on 2% agarose gels, visualized with ethidium bro-
mide and analyzed using the gel documentation system
AIDA 1D Evaluation (Raytest Isotopenmessgeräte
GmbH, Straubenhardt, Germany).
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